Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,304 | 447 | 1,453 | 2,999 | 368 |
| Other current assets | 48 | 11 | 12 | 11 | 5 |
| TOTAL | $3,822 | $628 | $1,761 | $3,272 | $511 |
| Non-Current Assets | |||||
| PPE Net | 167 | 174 | 126 | 128 | 58 |
| Intangibles | 95 | 87 | 6 | 19 | 37 |
| Other Non-Current Assets | 131 | -87 | 0 | 0 | 0 |
| TOTAL | $393 | $174 | $132 | $147 | $95 |
| Total Assets | $4,215 | $802 | $1,893 | $3,419 | $606 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 374 | 30 | 10 | 1 | 19 |
| Accounts payable and accrued liabilities | 36 | 96 | 39 | 45 | 15 |
| TOTAL | $1,546 | $658 | $838 | $535 | $284 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28 | 33 | 13 | N/A | 1 |
| Other Non-Current Liabilities | 1 | 6 | 11 | 16 | 0 |
| TOTAL | $29 | $39 | $24 | $16 | $1 |
| Total Liabilities | $1,575 | $697 | $862 | $551 | $285 |
| Shareholders' Equity | |||||
| Common Shares | 915 | 816 | 777 | 777 | 660 |
| Retained earnings | -11,221 | -9,508 | -8,194 | -6,357 | -2,889 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -2,468 |
| TOTAL | $2,640 | $105 | $1,031 | $2,868 | $-242 |
| Total Liabilities And Equity | $4,215 | $802 | $1,893 | $3,419 | $43 |